Clinical Trials in North Carolina

Showing 11661-11680 of 20,428 trials

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

NCT02553330

A phase 2 study to find out if the drug ruxolitinib Phosphate Cream is safe and has beneficial effects in people who have alopecia areata (partial or complete hair loss) when applied to the skin.

Alopecia Areata

Incyte Corporation90 participantsStarted Nov 2015

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • New Haven, Connecticut, United States +15 more locations

No Longer Available46 miles

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

NCT02475798

The purpose of this extended study is to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac aneurysms.

Aortoiliac AneurysmsIliac Aneurysms

Cook Research Incorporated

Phoenix, Arizona, United States • Palo Alto, California, United States • Stanford, California, United States +23 more locations

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Find Trials by Condition in North Carolina

Evaluation of Biomarkers of Traumatic Brain Injury

Fatty Acids and Executive Function Development in 7-12 Year Olds

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

The CDR Implementation Trial

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.

Efficacy and Safety of BGG492 in the Treatment of Migraine